Ligand-induced assembling of the type I interferon receptor on supported lipid bilayers - PubMed (original) (raw)
Ligand-induced assembling of the type I interferon receptor on supported lipid bilayers
Peter Lamken et al. J Mol Biol. 2004.
Abstract
Type I interferons (IFNs) elicit antiviral, antiproliferative and immuno-modulatory responses through binding to a shared receptor consisting of the transmembrane proteins ifnar1 and ifnar2. Differential signaling by different interferons, in particular IFNalphas and IFNbeta, suggests different modes of receptor engagement. Using reflectometric interference spectroscopy (RIfS), we studied kinetics and affinities of the interactions between IFNs and the extracellular receptor domains of ifnar1 (ifnar1-EC) and ifnar2 (ifnar2-EC). For IFNalpha2, we determined a K(D) value of 3 nM and 5 microM for the interaction with ifnar2-EC and ifnar1-EC, respectively. As compared to IFNalpha2, IFNbeta formed complexes with ifnar2-EC as well as ifnar1-EC with substantially higher affinity. For neither IFNalpha2 nor IFNbeta was stabilization of the complex with ifnar1-EC in the presence of soluble ifnar2-EC observed. We investigated ligand-induced complex formation with ifnar1-EC and ifnar2-EC being tethered onto solid-supported, fluid lipid bilayers by RIfS and total internal reflection fluorescence spectroscopy. We observed very stable binding of IFNalpha2 at high receptor surface concentrations with an apparent k(d) value approximately 200 times lower than that for ifnar2-EC alone. The apparent k(d) value was strongly dependent on the surface concentration of the receptor components, suggesting kinetic stabilization. This was corroborated by the fast exchange of labeled IFNalpha2 bound to the receptor by unlabeled IFNalpha2. Taken together, our results indicate that IFN first binds to ifnar2 and subsequently recruits ifnar1 in a transient fashion. In particular, this second step is much more efficient for IFNbeta than for IFNalpha2, which could explain differential activities observed for these IFNs.
Similar articles
- Differential receptor subunit affinities of type I interferons govern differential signal activation.
Jaks E, Gavutis M, Uzé G, Martal J, Piehler J. Jaks E, et al. J Mol Biol. 2007 Feb 16;366(2):525-39. doi: 10.1016/j.jmb.2006.11.053. Epub 2006 Nov 18. J Mol Biol. 2007. PMID: 17174979 - Comparable potency of IFNalpha2 and IFNbeta on immediate JAK/STAT activation but differential down-regulation of IFNAR2.
Marijanovic Z, Ragimbeau J, van der Heyden J, Uzé G, Pellegrini S. Marijanovic Z, et al. Biochem J. 2007 Oct 1;407(1):141-51. doi: 10.1042/BJ20070605. Biochem J. 2007. PMID: 17627610 Free PMC article. - Mutational and structural analysis of the binding interface between type I interferons and their receptor Ifnar2.
Piehler J, Schreiber G. Piehler J, et al. J Mol Biol. 1999 Nov 19;294(1):223-37. doi: 10.1006/jmbi.1999.3230. J Mol Biol. 1999. PMID: 10556041 - The Role of Structure in the Biology of Interferon Signaling.
Walter MR. Walter MR. Front Immunol. 2020 Nov 12;11:606489. doi: 10.3389/fimmu.2020.606489. eCollection 2020. Front Immunol. 2020. PMID: 33281831 Free PMC article. Review. - Safety, Tolerability, and Immunogenicity of Interferons.
Tovey MG, Lallemand C. Tovey MG, et al. Pharmaceuticals (Basel). 2010 Apr 20;3(4):1162-1186. doi: 10.3390/ph3041162. Pharmaceuticals (Basel). 2010. PMID: 27713294 Free PMC article. Review.
Cited by
- Stochastic receptor expression determines cell fate upon interferon treatment.
Levin D, Harari D, Schreiber G. Levin D, et al. Mol Cell Biol. 2011 Aug;31(16):3252-66. doi: 10.1128/MCB.05251-11. Epub 2011 Jun 20. Mol Cell Biol. 2011. PMID: 21690295 Free PMC article. - Slow-dissociation effect of common signaling subunit beta c on IL5 and GM-CSF receptor assembly.
Ishino T, Harrington AE, Zaks-Zilberman M, Scibek JJ, Chaiken I. Ishino T, et al. Cytokine. 2008 May;42(2):179-190. doi: 10.1016/j.cyto.2007.12.010. Epub 2008 Feb 21. Cytokine. 2008. PMID: 18294864 Free PMC article. - Alteration of interferon-α/β receptors in chronic hepatitis B patients.
Meng F, Wang J, Ge J, Fan X, Wang B, Han L, Kisseleva T, Paik Y, Brenner DA, Wang K. Meng F, et al. J Clin Immunol. 2011 Jun;31(3):521-32. doi: 10.1007/s10875-011-9518-6. Epub 2011 Mar 29. J Clin Immunol. 2011. PMID: 21445562 Free PMC article. - Ligand-independent interaction of the type I interferon receptor complex is necessary to observe its biological activity.
Krause CD, Digioia G, Izotova LS, Xie J, Kim Y, Schwartz BJ, Mirochnitchenko OV, Pestka S. Krause CD, et al. Cytokine. 2013 Oct;64(1):286-97. doi: 10.1016/j.cyto.2013.06.309. Epub 2013 Jul 3. Cytokine. 2013. PMID: 23830819 Free PMC article. - Early treatment with reverse transcriptase inhibitors significantly suppresses peak plasma IFNα in vivo during acute simian immunodeficiency virus infection.
George J, Renn L, Verthelyi D, Roederer M, Rabin RL, Mattapallil JJ. George J, et al. Cell Immunol. 2016 Dec;310:156-164. doi: 10.1016/j.cellimm.2016.09.003. Epub 2016 Sep 9. Cell Immunol. 2016. PMID: 27622386 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials